GZMB Antikörper (N-Term)
Kurzübersicht für GZMB Antikörper (N-Term) (ABIN2621682)
Target
Alle GZMB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human GZMB / Granzyme B
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Synthetic peptide corresponding to human Granzyme B at N-terminal.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (1:100)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM PBS, pH 7.4, BSA, sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- GZMB (Granzyme B (GZMB))
-
Andere Bezeichnung
- GZMB / Granzyme B
-
Hintergrund
-
Name/Gene ID: GZMB
Subfamily: Serine S1
Family: Protease
Synonyms: GZMB, CCPI, CGL-1, Cathepsin G-like 1, CSP-B, CTLA-1, CTLA1, CGL1, CSPB, Fragmentin 2, GRB, HLP, Human lymphocyte protein, Fragmentin-2, SECT, Lymphocyte protease, T-cell serine protease 1-3E, C11, CTSGL1, Cytotoxic serine protease B, Granzyme B, Granzyme-2 -
Gen-ID
- 3002
-
Pathways
- Apoptose, Caspase Kaskade in der Apoptose
Target
-